Our subsequent genetic complementation experiments showed that NRG1 promotes MPNST pathogenesis by activating erbB3 and erbB4-mediated signaling cascades that are dysregulated by neurofibromin loss [20]. Here, ERBB4 is linked to malignant peripheral nerve sheath tumor.